Resultados de la búsqueda

Lluis-Ganella C, Subirana I, Lucas G, Tomás M, Muñoz D, Sentí M, Salas E, Sala J, Ramos R, Ordovas JM, Marrugat J, Elosua R. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis (2012) 222:456-63

Yiannakouris N, Katsoulis M, Dilis V, Parnell LD, Trichopoulos D, Ordovas JM, Trichopoulou A. Genetic predisposition to coronary heart disease and stroke using an additive genetic risk score: A population-based study in Greece. Atherosclerosis (2012) 222:175-9

Caballero P, Alonso R, Rosado P, Mata N, Fernández-Friera L, Jiménez-Borreguero LJ, Badimon L, Mata P Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities. Atherosclerosis (2012) 222:468-72

Kovacic JC, Lee P, Baber U, Karajgikar R, Evrard SM, Moreno P, Mehran R, Fuster V, Dangas G, Sharma SK, Kini AS. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis (2012) 221:176-82

Fuster JJ*, Molina-Sánchez P*, Jovaní D, Vinué A, Serrano M, Andrés V (JJF and PMS contributed equally) Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice. Atherosclerosis (2012) 221:98-105
Link to the full text in Repisalud

Menéndez-Gutiérrez MP, Rőszer T, Ricote M. Biology and therapeutic applications of peroxisome proliferator-activated receptors. Curr Top Med Chem (2012) 12:548-84
Link to the full text in Repisalud

Rupérez FJ, Ramos-Mozo P, Teul J, Martinez-Pinna R, Garcia A, Malet-Martino M, Camafeita E, Lopez JA, Pastor-Vargas C, Egido J, Balayssac S, Gilard V, Barbas C, Martin-Ventura JL. Metabolomic study of plasma of patients with abdominal aortic aneurysm. Anal Bioanal Chem (2012) 403:1651-60

Frazier-Wood AC, Aslibekyan S, Borecki IB, Hopkins PN, Lai CQ, Ordovas JM, Straka RJ, Tiwari HK, Arnett DK. Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate. Pharmacogenet Genomics (2012) 22:750-7

Aslibekyan S, Kabagambe EK, Irvin MR, Straka RJ, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Shen J, Lai CQ, Ordovas JM, Arnett DK. A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenet Genomics (2012) 22:191-7

de la Fuente H*, Cibrián D*, Sánchez-Madrid F (HF and DC contributed equally) Immunoregulatory molecules are master regulators of inflammation during the immune response. FEBS Lett (2012) 586:2897-905